Retinopathy of Prematurity (ROP): Classification, Risk Factors and Treatment

Elmira Aguilar (Editor)

Series: Eye and Vision Research Developments
BISAC: MED064000

Clear

$130.00

Volume 10

Issue 1

Volume 2

Volume 3

Special issue: Resilience in breaking the cycle of children’s environmental health disparities
Edited by I Leslie Rubin, Robert J Geller, Abby Mutic, Benjamin A Gitterman, Nathan Mutic, Wayne Garfinkel, Claire D Coles, Kurt Martinuzzi, and Joav Merrick

eBook

Digitally watermarked, DRM-free.
Immediate eBook download after purchase.

Product price
Additional options total:
Order total:

Quantity:

Details

Retinopathy of prematurity is a disease caused by abnormal vessel regression of the retinal vasculature that affects premature infants with low birth weights. Despite significant improvements in screening guidelines and treatment modalties, ROP is still the leading cause of reversible paediatric blindness worldwide.

The authors of this book explore the possibility of applying the concept of fractal analysis to images of retinal blood vessels for morphometric analysis and classification; the quality of life for children with retinopathy of prematurity; the differences in ethnicity and socioeconomic status that influence the prevalence, risks, outcome and management of ROP; the outcome and prognostic factors of the intravitreal administration of bevacizumab for ROP; the outcomes of transpupillary diode laser photocoagulation for ROP; new therapeutic strategies for treating ROP and late complications that can develop and persistent into later childhood and even adult life (for example, long-term refractive errors, amblyopia, strabismus and optic nerve abnormalities).
(Imprint: Nova Biomedical)

Preface

Fractal and Multifractal Analysis of Two Dimensional Images of the Retinopathy of Prematurity: Morphologic Parameters and Classification
(Nebojša T. Miloševiæ, Nemanja Rajkoviæ, Herbert F. Jelinek, Department of Biophysics, School of Medicine, University of Belgrade, Serbia, and others)

Retinopathy of Prematurity in the Context with Quality of Life
(Kateøina Stejskalová, Institute of Special Education, Faculty of Education, Palacky University Olomouc, Czech Republic)

Management of Retinopathy of Prematurity: Past and Future
(Gordon Shing Kin Yau, Jacky Wai Yip Lee, Benjamin Chung Yin Chu, Victor Tak Yau Tam, Department of Ophthalmology, Caritas Medical Centre, Hong Kong SAR, China)

Intravitreal Bevacizumab in the Treatment of Retinopathy of Prematurity
(Simona Delia Nicoarã and Tudor Cãtãlin Drugan, "Iuliu Hatieganu" University of Medicine and Pharmacy, Department of Ophthalmology, Cluj-Napoca, Romania, and others)

Indirect Diode Laser Photocoagulation in the Treatment of Retinopathy of Prematurity
(Simona Delia Nicoarã and Tudor Cãtãlin Drugan, "Iuliu Hatieganu" University of Medicine and Pharmacy, Department of Ophthalmology, Cluj-Napoca, Romania, and others)

Targeting the Beta-Adrenergic System to Treat Retinopathy of Prematurity: A New Therapeutic Approach?
(Luca Filippi, Maurizio Cammalleri, Massimo Dal Monte, Neonatal Intensive Care Unit, Medical Surgical Fetal-Neonatal Department, "A. Meyer" University Children's Hospital, Florence, Italy, and others)

Late Complications of Retinopathy of Prematurity
(Monika Ecsedy and Zsuzsa Recsan, Budapest Department of Ophthalmology, Semmelweis University, Hungary)

Index

You have not viewed any product yet.


SHOW ALL OF MY RECENTLY VIEWED BOOKS